HIGHLIGHTS OF PRESCRIBING INFORMATION WARNINGS …

1 HIGHLIGHTS OF PRESCRIBING INFORMATION These HIGHLIGHTS do not include all the INFORMATION needed to use ORBACTIV safely and effectively. See full PRESCRIBING INFORMATION for ORBACTIV. ORBACTIV (oritavancin) for injection, for intravenous use Initial Approval: 2014 _____ RECENT MAJOR CHANGES _____ WARNINGS and Precautions ( ) 3/2018 _____ INDICATIONS AND USAGE _____ ORBACTIV is a lipoglycopeptide antibacterial drug indicated for the treatment of adult patients with acute bacterial skin and skin structure infections caused or suspected to be caused by susceptible isolates of designated Gram-positive microorganisms. ( ) To reduce the development of drug - resistant bacteria and maintain the effectiveness of ORBACTIV and other antibacterial drugs, ORBACTIV should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria.

infections caused or suspected to be caused by susceptible isolates of designated Gram-positive microorganisms. (1.1) To reduce the development of drug-resistant bacteria and maintain the effectiveness of ORBACTIV and other antibacterial drugs, ORBACTIV should be used only to treat or prevent infections that are proven or strongly

Tags:

  Drug, Resistant, Infections

Information

Related search queries